You are here

Wound Closure Alternative Outperforms Staples, Sutures

Zip Device Faster to Apply, Minimizes Scarring

ZipLine Medical’s Zip device, a surgical wound-closure system, improved both patient outcomes and overall costs compared with surgical staples in two recent clinical studies.

The device is used to help close and hold together the outer skin after deeper layers of sutures are applied within a surgical incision. The noninvasive, flexible design is designed to minimize scarring (compared with staples, sutures or glue) while the wound heals.

In one study of patients receiving same-day replacements of both knees, participants demonstrated greater range of motion in the two weeks following the procedure and reported less pain from the knee closed with the Zip device compared to the knee closed with staples. A blinded panel of plastic surgeons noted improvements in scar quality.

In a separate health economics study analyzing the records of 130 total knee replacements, patients who received surgical staples had more incision-related emergency room admissions, as well as related visits and phone calls into the clinic. They were also prescribed more antibiotics due to complications.

Previous clinical studies have also shown that Zip skin closure is up to three times faster to apply than sutures. The Zip device has been evaluated in total joint arthroplasty; orthopedic spine, foot, and ankle procedures; cardiothoracic, electrophysiology and emergency medicine surgeries; and in plastic and reconstructive surgery.

Roger Emerson, of the Texas Center for Joint Replacement, author of the first study, says the findings “provide insight on how a simple change in the closure methodology can lead to potential downstream cost savings, especially in a bundled payment model.” 

Source: FierceBiotech, August 14, 2019

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks